Nutra Pharma Corp.
NPHC
$0.0003
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -96.26% | -119.46% | 114.74% | 206.66% | 2,525.62% |
| Total Depreciation and Amortization | -21.61% | 68.46% | 1,238.89% | 631.03% | 15.19% |
| Total Amortization of Deferred Charges | 45.44% | 100.75% | 87.64% | 91.28% | 320.54% |
| Total Other Non-Cash Items | 93.56% | 103.60% | -116.47% | -268.27% | -1,677.41% |
| Change in Net Operating Assets | 61.92% | 212.44% | 214.81% | 79.78% | -37.77% |
| Cash from Operations | 59.97% | 43.44% | 56.55% | 33.76% | -201.17% |
| Capital Expenditure | 100.00% | 100.00% | -480.00% | 27.12% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 152.50% | 91.39% | 85.96% | -- | -- |
| Cash from Investing | 150.00% | 92.62% | -61.04% | -176.27% | -- |
| Total Debt Issued | -50.52% | -55.00% | -77.77% | -9.68% | 340.58% |
| Total Debt Repaid | -888.16% | -23.56% | -26.21% | -58.44% | 60.62% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -78.84% | -56.98% | -62.76% | -17.45% | 536.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.46% | -92.81% | -4,766.67% | -- | 90.16% |